- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Antiobesity Medications: Expert Compares Benefits, Drawback Among Classes
Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
In a recent interview with Patient Care Online, medical weight management specialist Sandra Christensen, MSN, ARNP, was asked the following question:
Ms Christensen discusses how the different classes of antiobesity medications compare in cost, side effect profiles, and more in the video below.
For a primer on common antiobesity medications, check out part 1 of our interview with Ms Christensen: Antiobesity Medications: Expert Discusses Older, Newer Therapies
Sandra Christensen, MSN, ARNP, is the owner of Integrative Medical Weight Management in Seattle, Washington.
Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis
December 2nd 2025Biomarker trajectories over 5 years in study participants with AD show steeper rises in pTau217, NfL, and amyloid burden among those with obesity, highlighting risk factor relevance.
